Dinoop Ravindran Menon

6PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 27, 2026
Bivalent CD47 Immunotoxin for Targeted Therapy of Lung Cancer.

|Jan 28, 2026
Human Alpha-1 Antitrypsin Suppresses Melanoma Growth by Promoting Tumor Differentiation and CD8+ T-Cell-Mediated Immunity.

Takeshi Yamauchi, Yuchun Luo, Dinoop Ravindran Menon

|Oct 27, 2022
Alcohol as a Non-UV Social-Environmental Risk Factor for Melanoma.

Takeshi Yamauchi, Sarah Shangraw, Zili Zhai

|Nov 27, 2021
EGCG Inhibits Tumor Growth in Melanoma by Targeting JAK-STAT Signaling and Its Downstream PD-L1/PD-L2-PD1 Axis in Tumors and Enhancing Cytotoxic T-Cell Responses.

Dinoop Ravindran Menon, Yang Li, Takeshi Yamauchi

|Mar 02, 2021
Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.

Isak W Tengesdal, Dinoop R Menon, Douglas G Osborne

Pageof 1

Frequent Collaborators

5 joint publications

Mayumi Fujita

3 joint publications

Zili Zhai

2 joint publications

Takeshi Yamauchi

1 joint publications

Douglas G Osborne